[go: up one dir, main page]

WO2011008111A1 - Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation - Google Patents

Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation Download PDF

Info

Publication number
WO2011008111A1
WO2011008111A1 PCT/PL2009/000075 PL2009000075W WO2011008111A1 WO 2011008111 A1 WO2011008111 A1 WO 2011008111A1 PL 2009000075 W PL2009000075 W PL 2009000075W WO 2011008111 A1 WO2011008111 A1 WO 2011008111A1
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
favourably
amount
weight
amounts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/PL2009/000075
Other languages
French (fr)
Inventor
Tadeusz Cieslik
Jacek Nocon
Jan Rauch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/PL2009/000075 priority Critical patent/WO2011008111A1/en
Publication of WO2011008111A1 publication Critical patent/WO2011008111A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/10Ceramics or glasses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608Bone, e.g. demineralised bone matrix [DBM], bone powder

Definitions

  • the subject of the invention is a preparation for regeneration of postoperative and post-traumatic bone defects and method for implantation of this preparation, employed in many branches of medicine especially in orthopedics, dental surgery, reconstructive surgery, periodenthology and implantology.
  • xenogeneic grafts or implants e.g. compositions of horse bone and cattle bone create a risk of transmission of animal diseases, e.g. BSE (Bovine Spongiform Encephalopathy).
  • BSE Bovine Spongiform Encephalopathy
  • pathogenic micro-organisms There is also a potential risk of transmission of pathogenic micro-organisms.
  • the objective of this invention is creating a new therapeutically effective preparation for regeneration bone defects, which will show low biotoxicity and small systematic side effects at surgical application.
  • This invention helps to fulfill the above task.
  • the preparation components have been marked with letters A, B, C, TCP.
  • the essence of this preparation is application of a deproteinized human bone (A), deprived of the smallest molecules of protein, with granulation from 0,3 to 0,5mm, bioglass (B) with granulation from 0,3 to 0,5mm and binder (C) favourably in the form of a patient's own blood in the amount of 20-25% in relation to the quantitative sum of the above components.
  • A human bone
  • tissue bank in the form of hydroxyapatite, with appropriate granulation, as well as in the form of trochlea.
  • the second component of the preparation bioglass (B), in the form of powder with granulation 0,3-0, 5mm, can be obtained with use of zol-gel method in the system CaO-SiCh-PiOs.
  • This component can also be used as a high silica component (80% mol. SiOa) or/and as a high calcium component (54% mol. CaO).
  • TCP tricalcium phosphate
  • This invention enables a faster regeneration of human bone tissue defects arising from intended activities, such as surgical activities, or unintended activities - injuries and disease process.
  • Application of the above preparation results in a fast and complete regeneration of anatomic profile and physiological function.
  • This invention helps to speed up the process of regeneration of damaged bone, and it contributes to compensation of biodegradation during the process of healing, due to active surfaces of the applied filler.
  • an appropriate amount of the preparation is being mixed with binder i.e. the blood from operative wound (the mixture should be homogeneous).
  • binder i.e. the blood from operative wound
  • the mixture which has consistency of Plasticine
  • the obtained mixture which has consistency of Plasticine, is implanted into bone defects.
  • Application of a patient's own blood enriches the implanted preparation with organic components, e.g. collagen type 1, proteins, polysaccharides, lipids, necessary for osteogenesis and for preventing the preparation components from moving inside the operative wound.
  • the components contained in a regenerating bone amount to 25% of the bone's weight.
  • the components enumerated above, especially collagen increase bone's resistance to mechanical destruction caused by tension that occurs during work, and reduce brittleness of bones. More over collagen and protein fibers accelerate crystallization of hydroxyapatite.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ceramic Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

According to the invention preparation for regeneration of bone defects is employed in many branches of medicine, especially in orthopedics, dental surgery, reconstructive surgery, periodonthology and implantology. The preparation has been developed on the basis of inorganic chemical compound naturally occurring, i.e. deproteinized human bone, and on the basis of at least one of inorganic chemical compounds synthetically occurring, i.e. bioglass in the form of granulated highcalcium product (54% mol. CaO), obtained with the use of zol-gel method in the system CaO-SiO2-P2O5, of density 2,9082 g/cm3, with phase composition with a dominant glassy phase and beginnings of crystallization of apatite, heat treated at temperature of 800°C, having a specific surface BET 57,8166 m2/g and/or tricalcium phosphate - TCP in the form of granulated product with chemical formula Ca3 (PO4)2. As a component deproteinized particlesof human bone are used, favourably with granulation 0,3-0,5 mm, bioglass favourably with granulation 0,3-0,5 mm and/or TCP — tricalcium phosphate favourably with granulation 0,3-0,5 mm. The amount of bone material in the preparation amounts favourably to 70-80% of the preparation weight, the amount of bioglass in preparation amounts favourably to 10-15% of the preparation weight, the amount of TCP in the preparation amounts favourably to 10-15% of the preparation weight. During implantation binder in the form of blood from patient's operative wound is introduced into the preparation. Amount of the preparation in mixture favourably amounts to 75-80% of the mixture weight and the amount of own blood favourably amounts to 20-25% of the mixture weight.

Description

PREPARATION FOR REGENERATION OF POSTOPERATIVE, POST-TRAUMATIC BONE
DEFECTS AND METHOD FOR IMPLANTATION OF THIS PREPARATION
The subject of the invention is a preparation for regeneration of postoperative and post-traumatic bone defects and method for implantation of this preparation, employed in many branches of medicine especially in orthopedics, dental surgery, reconstructive surgery, periodenthology and implantology.
Nowadays popularly applied xenogeneic grafts or implants e.g. compositions of horse bone and cattle bone create a risk of transmission of animal diseases, e.g. BSE (Bovine Spongiform Encephalopathy). There is also a potential risk of transmission of pathogenic micro-organisms.
There are also autogenic bone implants of patient's own bone, most often taken from oral cavity area. Bone can also be collected from other patient's anatomic areas, but it cannot be done in a dentist's office. Most often such surgery is performed in a clinic.
The objective of this invention is creating a new therapeutically effective preparation for regeneration bone defects, which will show low biotoxicity and small systematic side effects at surgical application.
This invention helps to fulfill the above task. For purposes of clarity the preparation components have been marked with letters A, B, C, TCP. The essence of this preparation is application of a deproteinized human bone (A), deprived of the smallest molecules of protein, with granulation from 0,3 to 0,5mm, bioglass (B) with granulation from 0,3 to 0,5mm and binder (C) favourably in the form of a patient's own blood in the amount of 20-25% in relation to the quantitative sum of the above components. For making this preparation one could use human bone (A) available in tissue bank in the form of hydroxyapatite, with appropriate granulation, as well as in the form of trochlea. The second component of the preparation bioglass (B), in the form of powder with granulation 0,3-0, 5mm, can be obtained with use of zol-gel method in the system CaO-SiCh-PiOs. This component can also be used as a high silica component (80% mol. SiOa) or/and as a high calcium component (54% mol. CaO). High silica component of a density 2,4037 g/cm3, heat treated at temperature of 700 0C, amorphous, has a specific surface BET 297, 9663m2/g. Whereas high calcium component of a density 2,9082 g/cm3, with phase composition with a dominant glassy phase and beginnings of crystallization of apatite, heat treated at temperature of 800°C, has a specific surface BET 57,8166 m2/g. This kind of bioactive glass of preparation spontenaously forms union with maternity tissue and stimulates regeneration of bone tissue. Under "in vivo" conditions on the surface of biomaterial hydroxyapatite layer (HAp) crystallizes with chemical and mineralogical composition similar to bone HAp (natural). In this way an exceptionally durable chemical bond (bonding interface) is formed. In a living organism in the presence of bioglass numerous biochemical and biological processes take place, e.g. proteins adsorption, synchronized cells occurrences which result in a quick forming of administered bone tissue. The invention also anticipates that instead of bioglass (B), a tricalcium phosphate (TCP) could be applied - favourably with granulation 0,3-0,5mm, in the amount of 15-20% of the preparation weight.
Unexpectedly it has also turned out that it in possible to get very good therapeutic results in regeneration of bone defects, by compiling all the above mentioned components of the preparation. As components are simultaneously used deproteinized preparation of bone (A) with granulation 0,3 -0,5mm in the amount favourably 70-80% of the preparation weight, bioglass (B) in the form of granulated product in the amount favourably 10-15% of the preparation weight, tricalcium phosphate TCP favourably 10-15% of the preparation weight, and binder (C) favourably in the amount of 20-25% of the preparation weight in relation to the quantitative sum of the amount of the above components.
Particular components are mixed in strictly defined proportions and strictly defined granulation. There are several reasons why it should be done this way. The main reason is atrophy of bone structure during spontaneous healing of wounds that reaches 20-30% of volume. Application of deproteinized human bone supplements natural hydroxyapatite in a wound, TCP slows down the process of atrophy and in this way reduces biodegradation, whereas bioglass due to its biologically active surface stimulates osteogenesis and functions as space filler when not being subjected to biodegradation.
This invention enables a faster regeneration of human bone tissue defects arising from intended activities, such as surgical activities, or unintended activities - injuries and disease process. Application of the above preparation results in a fast and complete regeneration of anatomic profile and physiological function. This invention helps to speed up the process of regeneration of damaged bone, and it contributes to compensation of biodegradation during the process of healing, due to active surfaces of the applied filler.
According to this invention an appropriate amount of the preparation is being mixed with binder i.e. the blood from operative wound (the mixture should be homogeneous). The obtained mixture which has consistency of Plasticine, is implanted into bone defects. Application of a patient's own blood enriches the implanted preparation with organic components, e.g. collagen type 1, proteins, polysaccharides, lipids, necessary for osteogenesis and for preventing the preparation components from moving inside the operative wound. The components contained in a regenerating bone amount to 25% of the bone's weight. The components enumerated above, especially collagen, increase bone's resistance to mechanical destruction caused by tension that occurs during work, and reduce brittleness of bones. More over collagen and protein fibers accelerate crystallization of hydroxyapatite.

Claims

Patent claims
1. Preparation for regeneration of postoperative and post-traumatic bone defects based on inorganic chemical compound naturally occurring and synthetically occurring, is characterized by the fact that the said preparation contains as its component particles of deproteinized human bone (A) favourably with granulation from 0,3 to 0,5mm, bioglass (B) in the form of granulated product and binder (C), and the amount of bone material in the preparation amounts favourably to 80-85% of the preparation weight, bioglass favourably 15-20% of the preparation weight, and binder 20-25% of the preparation weight in relation to the sum of amounts of the above components.
2. According to the claim 1, the preparation is characterized by the fact, that bioglass (B) is obtained with use of zol-gel method in the system CaO-SiCh-PzOs as high silica material (80% mol Siθ2) or as a high calcium material (54% mol CaO).
3. According to the claim 1, the preparation is characterized by the fact, that a patient's own blood is favourably used as binder (C).
4. According to the claim 1 , the preparation is characterized by the fact that instead of bioglass (B) a tricalcium phosphate marked below as component TCP is applied, favourably with granulation 0,3 -0,5mm, and the amount of bone material (A) in the preparation amounts favourably to 80-85% of the preparation weight, and TCP favourably 15-20% of the preparation weight.
5. According to claims 1-4 the preparation is characterized by the fact that the following materials are applied as components: bone material (A) with granulation 0,3-0, 5mm favourably in the amount 70-80% of the preparation weight, bioglass (B) in the granulated product in the amount favourably 10-15% of the preparation weight, tricalcium phosphate TCP favourably in the amount 10-15% of the preparation weight and binder (C) favourably in the amount 20-25% of the preparation weight in relation to the sum of the amount of the bone components.
6. The manner of implantation of the preparation for regeneration of postoperative and post-traumatic bone defects is characterized by the fact that during operation an appropriate amount of the preparation is mixed with binder, i.e. the blood from operative wound (the mixture should be homogenous). The obtained mixture, which has consistency of Plasticine, is implanted into bone defects, and the amount of the preparation in the mixture favourably amounts to 75-80% of the mixture weight, and the amount of blood in the mixture favourably amounts to 20-25% of the mixture weight.
PCT/PL2009/000075 2009-07-17 2009-07-17 Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation Ceased WO2011008111A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/PL2009/000075 WO2011008111A1 (en) 2009-07-17 2009-07-17 Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PL2009/000075 WO2011008111A1 (en) 2009-07-17 2009-07-17 Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation

Publications (1)

Publication Number Publication Date
WO2011008111A1 true WO2011008111A1 (en) 2011-01-20

Family

ID=41796418

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2009/000075 Ceased WO2011008111A1 (en) 2009-07-17 2009-07-17 Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation

Country Status (1)

Country Link
WO (1) WO2011008111A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021247348A1 (en) * 2020-06-01 2021-12-09 Bone Solutions, Inc. Bio-material composition and methods of use

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577342A1 (en) * 1992-06-29 1994-01-05 Queen Mary And Westfield College Sintered hydroxyapatite compositions and method for the preparation thereof
WO1998040113A1 (en) * 1997-03-13 1998-09-17 University Of Florida Tissue Bank, Inc. Bone paste
US6235225B1 (en) * 1999-08-10 2001-05-22 Ngk Spark Plug Co., Ltd. Process for producing biocompatible implant material
WO2007084609A2 (en) * 2006-01-19 2007-07-26 Osteotech, Inc. Porous osteoimplant
EP2080528A1 (en) * 2008-01-17 2009-07-22 Tadeusz Cieslik Preparation for regeneration of post-operative and post-traumatic bone defects and method for implantation of this preparation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577342A1 (en) * 1992-06-29 1994-01-05 Queen Mary And Westfield College Sintered hydroxyapatite compositions and method for the preparation thereof
WO1998040113A1 (en) * 1997-03-13 1998-09-17 University Of Florida Tissue Bank, Inc. Bone paste
US6235225B1 (en) * 1999-08-10 2001-05-22 Ngk Spark Plug Co., Ltd. Process for producing biocompatible implant material
WO2007084609A2 (en) * 2006-01-19 2007-07-26 Osteotech, Inc. Porous osteoimplant
EP2080528A1 (en) * 2008-01-17 2009-07-22 Tadeusz Cieslik Preparation for regeneration of post-operative and post-traumatic bone defects and method for implantation of this preparation
US20090186063A1 (en) * 2008-01-17 2009-07-23 Tadeusz Cieslik Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERGMAN S A ET AL: "BONE IN-FILL OF NON-HEALING CALVARIAL DEFECTS USING PARTICULATE BIOGLASS AND AUTOGENOUS BONE", BIOCERAMICS, XX, XX, 1 January 1995 (1995-01-01), pages 17 - 24, XP000869797 *
HANKER J S ET AL: "SETTING OF COMPOSITE HYDROXYLAPATITE/PLASTER IMPLANTS WITH BLOOD FOR BONE RECONSTRUCTION", PROCEEDINGS OF THE ANNUAL MEETING OF THE ELECTRON MICROSCOPYSOCIETY OF AMERICA, XX, XX, vol. 22, 1 January 1986 (1986-01-01), pages 328/329, XP009025391 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021247348A1 (en) * 2020-06-01 2021-12-09 Bone Solutions, Inc. Bio-material composition and methods of use

Similar Documents

Publication Publication Date Title
US8303971B2 (en) Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation
US6117456A (en) Methods and products related to the physical conversion of reactive amorphous calcium phosphate
AU2005286719B2 (en) Multi-purpose bio-material composition
Fernandes et al. Calcium sulfate as a scaffold for bone tissue engineering: a descriptive review
Jazayeri et al. Dental applications of natural‐origin polymers in hard and soft tissue engineering
Al‐allaq et al. A review: In vivo studies of bioceramics as bone substitute materials
Lodoso-Torrecilla et al. Bioinorganic supplementation of calcium phosphate-based bone substitutes to improve in vivo performance: a systematic review and meta-analysis of animal studies
Lun et al. Limitations and modifications in the clinical application of calcium sulfate
Ana Bone substituting materials in dental implantology
Baino Ceramics for bone replacement: Commercial products and clinical use
Yassine et al. Repair of segmental radial defect with autologous bone marrow aspirate and hydroxyapatite in rabbit radius: A clinical and radiographic evaluation
Elshahat et al. The use of Novabone and Norian in cranioplasty: A comparative study
CA2748642C (en) Enhanced medical implant
Kirschner et al. Repair of the immature craniofacial skeleton with a calcium phosphate cement: quantitative assessment of craniofacial growth
Cutter et al. Bone grafts and substitutes
Pagani et al. Update on synthetic biomaterials combined with fibrin derivatives for regenerative medicine: Applications in bone defect treatment: Systematic review
Mehrvar et al. In vivo analysis of a proprietary glass-based adhesive for sternal fixation and stabilization using rabbit and sheep models
WO2006076426A2 (en) Multi-purpose bio-material composition
WO2003049780A1 (en) Biocompatible composite material with an osteotropic action
Harsini et al. Bone grafting and the materials for using in orthopaedics
McPherson et al. Bone grafting with coralline hydroxyapatite
WO2011008111A1 (en) Preparation for regeneration of postoperative, post-traumatic bone defects and method for implantation of this preparation
Komlev et al. Bioactivity and effect of bone formation for octacalcium phosphate ceramics
WO2017101021A1 (en) Modified bone repairing material
Mohan et al. Current implants used in cranioplasty

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09788410

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09788410

Country of ref document: EP

Kind code of ref document: A1